25717-80-0

Applied Filters:

Keyword:'25717-80-0'

Showing 1-10 of 523 results for "25717-80-0" within Site Content

Workflow for the Analysis of Polysorbate 80 in Erbitux® Formulation

A complete reversed phase HPLC-ELSD workflow, including sample preparation for the analysis of Polysorbate 80 in a monoclonal antibody formulation.

Protector RNase Inhibitor Protocol

Protector RNase Inhibitor stabilizes RNA at -80°C without permeating intact cells, unsuitable for cell pellet addition.

Merck's Bioprocessing 4.0 Technologies

Blazar™ platform wins R&D 100 and CPhI Awards for reducing testing times by up to 80 percent.

NHC-based Palladium Catalysts

In collaboration with Umicore AG and Co.,1 we are pleased to offer a series of robust Pd(II) and Pd(0) complexes employed as the linchpin in C–C bond forming reactions.

Accelerating Protein Degrader Discovery with IAP

Plate of 80 ligands against E3 ligase IAP designed by ComInnex; allows creation of bifunctional targeted protein degraders or molecular glues.

Dissecting MOCRA Modernization Cosmetic Regulations Act

MoCRA brings the most significant changes to US cosmetic regulations in 80 years, requiring companies to monitor FDA updates and adopt new compliance policies.

Louie Group – Professor Product Portal

Professor Louie's research focuses on the discovery and mechanistic understanding of new reactions catalyzed by transition metal complexes. She has developed a highly active Ni(0) catalyst that effectively mediates a variety of cycloaddition and isomerization reactions.

Size Exclusion Analysis of Tween-Containing IgG Formulations

In this study, we investigated the effect of adding Tween® 20 and Tween 80 on the elution of proprietary mAb 221 under size exclusion chromatography conditions.

Review of O-Linked Glycoproteins

O-Linked glycoproteins are usually large proteins with a molecular mass of >200 kDa. Glycosylation generally occurs in high-density clusters and may represent as much as 50-80% of the overall mass.

Biorepository & Storage

Store your precious material in GMP-compliant facilities amongst three continents. A range of materials including virus and cell banks can be stored in ambient, liquid nitrogen or –80 conditions.

Page 1 of 53